Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02180893 · ClinicalTrials.gov registry record · Phase 4
The Use of Paravertebral Block for Cardiac Surgery
A Phase 4 study, sponsored by NYU Langone Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT02180893 is a Phase 4 study that has completed, run by NYU Langone Health. The registered enrollment target is 60 participants.
The verdict
NCT02180893, a Phase 4 study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
Pain after robotic cardiac surgery is a known problem and is often difficult to manage. Paravertebral nerve blocks are a proven method of pain relief following thoracotomy. A paravertebral block has been shown to provide good pain relief with minimal side effects, however, paravertebral blocks for robotic surgery have not been well studied. Currently the investigators routinely perform PVB on this patient population (of 50 MV robotic cases done between January and October 2012, 36 received paravertebral blocks with no adverse events noted). The investigators believe this should be studied further and that paravertebral blocks will reduce the amount of additional pain medication patients require in the first 24 hours after surgery, decrease intubation time and improve PACU and hospital discharge times.
Interventions
- OTHER Placebo Comparator
- OTHER Paravertebral Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02180893
The ClinicalTrials.gov registry entry for NCT02180893 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Comparator is the first listed.
NCT02180893 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02180893 about?
NCT02180893 is a clinical study titled "The Use of Paravertebral Block for Cardiac Surgery". Pain after robotic cardiac surgery is a known problem and is often difficult to manage. Paravertebral nerve blocks are a proven method of pain relief following thoracotomy. A paravertebral block has been shown to provide good pain relief with minimal side effects, however, paravertebral blocks for r...
What is the current status of trial NCT02180893?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2013-01. Estimated completion is 2014-04.
What interventions are being tested in trial NCT02180893?
The interventions under investigation include: Placebo Comparator (OTHER), Paravertebral Block (OTHER).
Who is sponsoring clinical trial NCT02180893?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.